{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:41:57Z","timestamp":1790790117329,"version":"4.1.0"},"reference-count":115,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2017.00193","type":"journal-article","created":{"date-parts":[[2017,6,18]],"date-time":"2017-06-18T23:46:59Z","timestamp":1497829619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":146,"title":["Microglial Activation in the Pathogenesis of Huntington\u2019s Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Hui-Ming","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei-Sha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Feng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease.","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B2","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains.","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11758","article-title":"Human glia can both induce and rescue aspects of disease phenotype in Huntington disease.","volume":"7","author":"Benraiss","year":"2016","journal-title":"Nat. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.phrs.2016.07.021","article-title":"Type-2 cannabinoid receptors in neurodegeneration.","volume":"111","author":"Bisogno","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease.","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/cdd.2015.11","article-title":"The CB(1) cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway.","volume":"22","author":"Blazquez","year":"2015","journal-title":"Cell Death Differ."},{"key":"B7","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","article-title":"Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of huntington\u2019s disease.","volume":"32","author":"Bouchard","year":"2012","journal-title":"J. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","article-title":"Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.","volume":"285","author":"Bradford","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model.","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.2147\/DDDT.S58470","article-title":"Transgenic animal models for study of the pathogenesis of Huntington\u2019s disease and therapy.","volume":"9","author":"Chang","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbi.2013.02.005","article-title":"Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro.","volume":"32","author":"Chhor","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity.","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.celrep.2013.06.018","article-title":"A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model.","volume":"4","author":"Chiu","year":"2013","journal-title":"Cell Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.intimp.2014.12.035","article-title":"IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells.","volume":"24","author":"Cianciulli","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nn.3668","article-title":"Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.","volume":"17","author":"Crotti","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington\u2019s disease.","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6986175","article-title":"Exploring new inflammatory biomarkers and pathways during LPS-induced M1 polarization.","volume":"2016","author":"Cunha","year":"2016","journal-title":"Mediators Inflamm."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates.","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-6-55","article-title":"Changes of peripheral TGF-beta1 depend on monocytes-derived macrophages in Huntington disease.","volume":"6","author":"Di Pardo","year":"2013","journal-title":"Mol. Brain"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/srep29789","article-title":"VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington\u2019s disease.","volume":"6","author":"Diaz-Alonso","year":"2016","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"B23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.55782\/ane-2014-1985","article-title":"Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet.","volume":"74","author":"Donat","year":"2014","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162404","article-title":"Huntingtons disease mice infected with Toxoplasma gondii demonstrate early kynurenine pathway activation, altered CD8+ T-cell responses, and premature mortality.","volume":"11","author":"Donley","year":"2016","journal-title":"PLoS ONE"},{"key":"B25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/glia.22298","article-title":"Comparison of polarization properties of human adult microglia and blood-derived macrophages.","volume":"60","author":"Durafourt","year":"2012","journal-title":"Glia"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/srep06824","article-title":"Toll-like receptors 2, -3 and -4 prime microglia but not astrocytes across central nervous system regions for ATP-dependent interleukin-1beta release.","volume":"4","author":"Facci","year":"2014","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","article-title":"Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease.","volume":"45","author":"Franciosi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pneurobio.2015.05.003","article-title":"Alternatively activated microglia and macrophages in the central nervous system.","volume":"131","author":"Franco","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.01.011","article-title":"L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: focus on cell type differences.","volume":"112","author":"Fujigaki","year":"2017","journal-title":"Neuropharmacology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0463-9","article-title":"Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines.","volume":"13","author":"Ghosh","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle.","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ng1542","article-title":"A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.","volume":"37","author":"Giorgini","year":"2005","journal-title":"Nat. Genet."},{"key":"B34","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1124\/mol.56.6.1362","article-title":"Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors.","volume":"56","author":"Glass","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/1073858414530512","article-title":"Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity.","volume":"21","author":"Gomez-Nicola","year":"2015","journal-title":"Neuroscientist"},{"key":"B36","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease.","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"B39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","article-title":"Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice.","volume":"23","author":"Guidetti","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington\u2019s disease.","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia"},{"key":"B42","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology.","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain.","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.1523\/JNEUROSCI.1830-07.2007","article-title":"Longitudinal evaluation of the Hdh((CAG)150) knock-in murine model of Huntington\u2019s disease.","volume":"27","author":"Heng","year":"2007","journal-title":"J. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1042\/bj3200595","article-title":"Human microglia convert L-tryptophan into the neurotoxin quinolinic acid.","volume":"320","author":"Heyes","year":"1996","journal-title":"Biochem. J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.","author":"Heyes","year":"1992","journal-title":"Brain"},{"key":"B47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-kappaB-dependent inflammation in Huntington\u2019s disease.","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","article-title":"Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u2019s disease.","volume":"23","author":"Hsiao","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrneurol.2014.207","article-title":"Microglial and macrophage polarization-new prospects for brain repair.","volume":"11","author":"Hu","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","article-title":"Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.","volume":"85","author":"Huang","year":"2015","journal-title":"Neuron"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.4049\/jimmunol.175.7.4320","article-title":"TLR signaling tailors innate immune responses in human microglia and astrocytes.","volume":"175","author":"Jack","year":"2005","journal-title":"J. Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/glia.23050","article-title":"Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific.","volume":"65","author":"Jansen","year":"2017","journal-title":"Glia"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2015.11.003","article-title":"Functional polarization of neuroglia: implications in neuroinflammation and neurological disorders.","volume":"103","author":"Jha","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity.","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"621.e17","DOI":"10.1016\/j.neurobiolaging.2011.02.015","article-title":"Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons.","volume":"33","author":"Kraft","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.neuron.2014.07.027","article-title":"TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord.","volume":"83","author":"Kroner","year":"2014","journal-title":"Neuron"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/srep41271","article-title":"Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.","volume":"7","author":"Lanz","year":"2017","journal-title":"Sci. Rep."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00089","article-title":"Protective microglia and their regulation in Parkinson\u2019s Disease.","volume":"9","author":"Le","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/78054","article-title":"Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity.","volume":"25","author":"Li","year":"2000","journal-title":"Nat. Genet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0896-6273(93)90127-D","article-title":"Huntingtons-Disease gene (It-15) is widely expressed in human and rat-tissues.","volume":"11","author":"Li","year":"1993","journal-title":"Neuron"},{"key":"B62","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia.","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1096\/fj.12-219220","article-title":"A novel human embryonic stem cell-derived Huntington\u2019s disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.","volume":"27","author":"Lu","year":"2013","journal-title":"FASEB J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","article-title":"The kynurenine pathway and neurodegenerative disease.","volume":"40","author":"Maddison","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0458-6","article-title":"Ligand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytes.","volume":"12","author":"Marinelli","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"B67","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia.","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175.","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS ONE"},{"key":"B69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats.","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington\u2019s disease.","volume":"117","author":"Moller","year":"2010","journal-title":"J. Neural Trans."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148001","article-title":"Call Off the Dog(ma): M1\/M2 polarization is concurrent following traumatic brain injury.","volume":"11","author":"Morganti","year":"2016","journal-title":"PLoS ONE"},{"key":"B73","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation.","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.neuron.2016.03.016","article-title":"PIAS1 regulates mutant huntingtin accumulation and Huntington\u2019s Disease-associated phenotypes In Vivo.","volume":"90","author":"Ochaba","year":"2016","journal-title":"Neuron"},{"key":"B75","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states.","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/brain\/awt083","article-title":"Reactive glia show increased immunoproteasome activity in Alzheimer\u2019s disease.","volume":"136","author":"Orre","year":"2013","journal-title":"Brain"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity.","volume":"132","author":"Palazuelos","year":"2009","journal-title":"Brain"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study.","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease.","volume":"10","author":"Perry","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington\u2019s disease gene carriers.","volume":"83","author":"Politis","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington\u2019s disease: a multimodal imaging study.","volume":"32","author":"Politis","year":"2011","journal-title":"Hum. Brain. Mapp."},{"key":"B83","doi-asserted-by":"publisher","first-page":"10714","DOI":"10.1523\/JNEUROSCI.1922-07.2007","article-title":"CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells.","volume":"27","author":"Ponomarev","year":"2007","journal-title":"J. Neurosci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbi.2016.07.004","article-title":"Increased irritability, anxiety, and immune reactivity in transgenic Huntington\u2019s disease monkeys.","volume":"58","author":"Raper","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163479","article-title":"Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington\u2019s Disease.","volume":"11","author":"Rodrigues","year":"2016","journal-title":"PLoS ONE"},{"key":"B86","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: from molecular pathogenesis to clinical treatment.","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/glia.20838","article-title":"Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington\u2019s Disease.","volume":"57","author":"Sagredo","year":"2009","journal-title":"Glia"},{"key":"B88","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain.","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1006\/taap.1996.8034","article-title":"Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.","volume":"142","author":"Schatz","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.034439","article-title":"Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities.","volume":"303","author":"Schwarcz","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B92","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.immuni.2013.02.012","article-title":"Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus.","volume":"38","author":"Shechter","year":"2013","journal-title":"Immunity"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity.","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease.","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"B95","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington\u2019s disease.","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp. Neurol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1093\/hmg\/ddw212","article-title":"An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes.","volume":"25","author":"Southwell","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B97","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuroscience.2016.01.035","article-title":"The role of autophagy in modulation of neuroinflammation in microglia.","volume":"319","author":"Su","year":"2016","journal-title":"Neuroscience"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.2174\/092986712800167365","article-title":"Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects.","volume":"19","author":"Szalardy","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brainresbull.2006.10.029","article-title":"Imaging microglial activation in Huntington\u2019s disease.","volume":"72","author":"Tai","year":"","journal-title":"Brain Res. Bull."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers.","volume":"130","author":"Tai","year":"","journal-title":"Brain"},{"key":"B101","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways.","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin. Immunol."},{"key":"B102","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded, and unstable on Huntington\u2019s disease chromosomes.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"B103","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/brain\/awt355","article-title":"HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NFkappaB pathway dysregulation.","volume":"137","author":"Trager","year":"2014","journal-title":"Brain"},{"key":"B104","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13311-014-0304-z","article-title":"Neuroprotective properties of cannabigerol in Huntington\u2019s Disease: studies in R6\/2 Mice and 3-nitropropionate-lesioned mice.","volume":"12","author":"Valdeolivas","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B105","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jneuroim.2016.02.012","article-title":"Revelation of the IFNalpha, IL-10, IL-8 and IL-1beta as promising biomarkers reflecting immuno-pathological mechanisms in porcine Huntington\u2019s disease model.","volume":"293","author":"Valekova","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.conb.2015.10.004","article-title":"Microglial genes regulating neuroinflammation in the progression of Alzheimer\u2019s disease.","volume":"36","author":"Villegas-Llerena","year":"2016","journal-title":"Curr. Opin. Neurobiol."},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-015-0139-9","article-title":"Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.","volume":"7","author":"Walker","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12031-015-0678-3","article-title":"TRAM1 promotes microglia M1 polarization.","volume":"58","author":"Wang","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington\u2019s disease.","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","article-title":"Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse.","volume":"8","author":"Wheeler","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"B111","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","article-title":"Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in huntington disease patient-derived induced pluripotent stem cells.","volume":"8","author":"Xu","year":"2017","journal-title":"Stem Cell Rep."},{"key":"B112","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s13311-014-0277-y","article-title":"Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma.","volume":"11","author":"Zanier","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B113","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease.","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"B114","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1523\/JNEUROSCI.0806-16.2016","article-title":"Compartment-dependent degradation of mutant huntingtin accounts for its preferential accumulation in neuronal processes.","volume":"36","author":"Zhao","year":"2016","journal-title":"J. Neurosci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2017.00193\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T16:53:48Z","timestamp":1719248028000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2017.00193\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,19]]},"references-count":115,"alternative-id":["10.3389\/fnagi.2017.00193"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2017.00193","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,19]]},"article-number":"193"}}